Home About Us Pipeline Investors News & Events Careers Contact Us
S*BIO Vision | Background | S*BIO Management | Board of Directors | Scientific Advisory Board | Corporate Values
Clinical Trials | R&D Programmes | Technologies & Capabilities | S*BIO’s Functional Capabilities | Publications
Investors | Partnerships
News & Press Releases | Participation in Events
Join Our Team | Job Openings | How to Apply

The best scientist is open to experience and begins with romance - the idea that anything is possible.
Ray Bradbury



2006 Events


Date
Event
Dec 2006 9th International Symposium for Chinese Organic Chemists (ISCOC-9)
S*BIO will be presenting an oral and several poster presentations at the upcoming ISCOC-9. The oral presentation's abstract entitled "Design, synthesis, and SAR of novel benzimidazole based HDAC inhibitors" will highlight the synthesis, SAR and biological profiles of SB639 series, one of S*BIO's orally active HDAC inhibitor series.

Presentation:
Venue:
Tuesday, December 19, 2006, 10:40am
GALLERIA I, Grand Copthorne Waterfront Hotel, Singapore

Nov 2006 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
S*BIO will be presenting 2 posters at the upcoming EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics" in Prague. These posters entitled "Pharmacological profile of SB939, a novel potent and orally active histone deacetylase inhibitor" and "ADME and PK/PD attributes of SB939, a potent orally active HDAC inhibitor" present for the first time the attractive pharmacological and pharmacokinetic profile of S*BIO's lead histone deacetylase inhibitor, SB939.

Poster Presentations:

Poster No:
Venue:
Wednesday to Friday, November 8 to 10, 2006, 12:00pm to 3:00pm
162 and 166
Prague Congress Centre, Prague, Czech Republic

Nov 2006 BIO-Europe 2006 - 12th Annual International Partnering Conference
Dr Jan-Anders Karlsson, CEO of S*BIO will present at the upcoming BIO-Europe 2006 conference. He will introduce S*BIO and highlight the significant progress made in the discovery and development programmes.

Presentation:
Venue:
Wednesday, November 8, 2006, 9:45am
Congress Center - Room 28 Level 2, Duesseldorf, Germany

Oct 2006 Economic Development Board (EDB) Drug Discovery Course
Dr Brian Dymock, Head of Chemistry for S*BIO will deliver two presentations on Lead Indentification in Drug Discovery to an audience of EDB staff. These lectures will be part of a one-day course supported by colleagues from other Singapore companies, Novartis, GSK and Maccine

Presentation:
Venue:
Friday, October 20, 2006
Matrix Building, Biopolis

Oct 2006 3rd Annual Asia Pacific Life Science Forum, Rodman & Renshaw Elixir / Intersuisse Bioscience
Dr Jan-Anders Karlsson, CEO of S*BIO, will present at the 3rd Annual Asia Pacific Life Science Forum in London. He will introduce S*BIO and highlight the significant progress that has been achieved in discovery and development programmes.

Presentation:
Venue:
Thursday, October 12, 2006, 9:50 am
The Cumberland Hotel, London

Oct 2006 14th Annual BioPartnering Europe
Dr Stephen Rhind, SVP, Corporate Development of S*BIO will attend the 14th Annual BioPartnering Europe in London for business development and licensing meetings.

Date:
Venue:
Sunday to Tuesday, October 8 to 10, 2006
The Queen Elizabeth II Conference Centre, London, United Kingdom

Oct 2006 Workshop on Molecular Targets for Cancer, European Commission DG RTD, CRP Santé
Dr Jeanette Wood, Head of Biology, is one of the 22 distinguished invited speakers participating in this workshop. She will give a presentation entitled "Targeted therapies with potentially broad applications: how can the development strategy be focused?" and will use histones deacetylase inhibitors as one example. She will also chair the closing round table discussion on challenges of developing novel molecular targets into applications.

Presentation:

Venue:
Saturday, October 7, 2006, 2.30pm and 4.00pm - 6.00pm
Abbaye de Neumünster, Quartier Luxembourg-Grund, 28 Rue Münster, Luxembourg

Sep 2006 2006 Atlas Venture Life Sciences Retreat
Dr Stephen Rhind, SVP, Corporate Development of S*BIO, will present at the 2006 Atlas Venture Life Sciences Retreat in Saint Jean Cap Ferrat, France. He will introduce S*BIO and highlight the significant progress that has been achieved in discovery and development programmes.

Presentation:
Venue:
Monday, September 18, 2006, 4:15pm
The Hotel Royal Riviera, Saint Jean Cap Ferrat, France

Sep 2006 Run For Hope 2006
Supporting cancer research in the lab and on the road

For the second year running, S*BIO will be supporting the Run For Hope 2006 (previously named Terry Fox Run), which is dedicated to raising funds for cancer control, treatment and care. Support will be provided through participation in the 9KM Competitive Race, the 5KM Fun Run and through sponsoring for the event. S*BIO employees will be running or walking at this annual event, which is held on 17 September 2006, at the Tanjong Beach, Sentosa.
Sep 2006 4th Life Sciences Career Day 2006
Sep 2006 The 16th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling
S*BIO will be presenting poster at the upcoming 16th European Symposium on Quantitative Structure-Activity Relationships & Molecular Modelling. The poster entitled "A Web-based docking interface for the bench chemist" will discuss a proprietary tool used for structure-based drug design and for communicating ideas on novel compounds within the company.

Poster Presentation:

Venue:
Tuesday, September 12, 2:00pm &
Thursday, September 14, 2006, 2:00pm
On board the ship OPERA, departing from Civitavecchia, Italy on September 10, 2006, 6:00pm
Sep 2006 American Chemical Society 232nd National Meeting & Exposition
S*BIO will be presenting an oral and a poster presentation at the upcoming ACS National Meeting in San Francisco, USA. The abstract entitled "Design, synthesis, and SAR of novel benzimidazole based HDAC inhibitors" will highlight the synthesis, SAR and biological profiles of SB639 series, one of S*BIO's orally active HDAC inhibitor series.

Poster Presentation:
Venue:
Poster Session ID:
Sunday, September 10, 2006, 7:00pm
Moscone Convention Center – Hall D, San Francisco
MEDI 146
Oral Presentation:
Venue:
Abstract #:
Thursday, September 14, 2006, 2:30pm
Moscone Convention Center - Room 102, San Francisco
MEDI 575
Jun 2006 The Atlas Venture Japan Biopharma Partnering Conference 2006, Tokyo
Dr. Jan-Anders Karlsson, Chief Executive Officer of S*BIO, will present at the Atlas Venture Japan Biopharma Partnering Conference. He will introduce S*BIO and highlight the significant progress in its development programmes.

Presentation:
Venue:
Tuesday, June 20, 2006, 10:00 am
Park Hyatt Hotel, Tokyo
Jun 2006 ISSX 2006 - Manchester
S*BIO will be presenting a poster at the upcoming ISSX 2006 meeting in Manchester, UK. The poster entitled “Comparative Pharmacokinetics of HDAC Inhibitors in Pharmacological Species” will highlight the superior pharmacokinetic properties of S*BIO's novel HDAC inhibitor.

Presentation:
Venue:
Abstract #:
Poster Session ID:

Monday, June 5, 2006, 9:00 am to 5:00 pm
Manchester International Convention Centre
77
Pharmacokinetics

Apr 2006 BIO2006 Annual International Convention, Chicago
Dr. Jan-Anders Karlsson, Chief Executive Officer of S*BIO, will present at the BIO2006 Annual International Convention. The presentation will highlight S*BIO's fully integrated research and development capabilities and its leading histone deacetylase inhibitor program.

Presentation:
Venue:


Monday, April 10, 2006, 3:30 pm CST
McCormick Place South, Level 3 Exhibit Hall A, Room E

S*BIO also invites all to visit its exhibition booth at the Singapore Pavilion (Booth 171) located in the BIO2006 Exhibit Hall.

For the Presentation slides, please contact us at invest@sbio.com

Apr 2006 AACR 97th Annual meeting, Washington DC
S*BIO will be presenting a poster at the upcoming 2006 AACR’s annual meeting held in April 2006. The poster will showcase a series of novel HDAC inhibitors developed by S*BIO that exhibit superior in vitro and in vivo properties as compared to known HDAC inhibitors.

Presentation:
Venue:
Abstract #:
Poster Session ID:

Tuesday, April 04, 2006, 8:00 am
Washington Convention Centre
3811
Experimental and Molecular Therapeutics 31

Feb 2006 BIO CEO & Investor Conference – New York City

Back to Events


Back to top



Copyright © 2002 S*BIO Pte Ltd. All rights reserved.